We further found that TCGA ccRCC patients with primary tumors expressing a high level of LTF transcript had a 72.2% 5-year survival rate, while patients with primary tumors harboring a low level of LTF transcript had a 23.1% 5-year survival rate (Figure 2A). This evidence concerns the gene LTF and nonpapillary renal cell carcinoma.